Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)

ConclusionsFirst-line chemotherapy with re-introduction of OX more than 6  months after adjuvant chemotherapy including OX can be used safely with expected efficacy for relapsed colon cancer patients.

Source: Cancer Chemotherapy and Pharmacology - February 8, 2021 Category: Cancer & Oncology Source Type: research